Somatic alterations of the SMAD-2 gene in human colorectal cancers
1998

Somatic Alterations of the SMAD-2 Gene in Human Colorectal Cancers

Sample size: 36 publication Evidence: low

Author Information

Author(s): Y Takagi, H Koumura, M Futamura, S Aoki, K Yamaguchi, H Kida, H Tanemura, K Shimokawa, S Saji

Primary Institution: Gifu University School of Medicine

Hypothesis

The study aims to determine the clinical alterations and significance of mutations in the SMAD-2 gene in colorectal cancers.

Conclusion

The SMAD-2 gene may play a role as a candidate tumor-suppressor gene in a small fraction of colorectal cancers.

Supporting Evidence

  • Only one missense mutation and two homozygous deletions of the SMAD-2 gene were detected in the 36 cancers.
  • The SMAD-2 mutation was present in an early stage lesion.
  • Alterations of MAD-related genes at 18q21 are involved in the pathogenesis of colon cancers.

Takeaway

Scientists looked at a gene called SMAD-2 in people with colon cancer and found some changes, but not many. This gene might help stop cancer from growing.

Methodology

Mutation analyses of the SMAD-2 gene were carried out on cDNA samples from 36 primary colorectal cancer specimens using PCR, SSCP, and DNA sequencing.

Limitations

The study only detected a low frequency of mutations in the SMAD-2 gene.

Participant Demographics

Japanese patients diagnosed with colorectal cancers.

Statistical Information

P-Value

0.0026

Statistical Significance

p=0.0026

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication